The Japan Times - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 3.823403
AFN 79.112634
ALL 98.10997
AMD 415.0708
ANG 1.876424
AOA 950.914404
ARS 1090.13111
AUD 1.659265
AWG 1.876324
AZN 1.780543
BAM 1.949902
BBD 2.102152
BDT 126.965967
BGN 1.955843
BHD 0.392336
BIF 3034.387996
BMD 1.040956
BND 1.408845
BOB 7.194067
BRL 6.185046
BSD 1.041156
BTN 90.014168
BWP 14.400374
BYN 3.407211
BYR 20402.746043
BZD 2.091384
CAD 1.498212
CDF 2961.52069
CHF 0.943445
CLF 0.037397
CLP 1031.910761
CNY 7.570149
CNH 7.580276
COP 4435.515352
CRC 523.618731
CUC 1.040956
CUP 27.585345
CVE 110.670924
CZK 25.141905
DJF 184.998195
DKK 7.460743
DOP 63.925349
DZD 140.627973
EGP 52.378434
ERN 15.614346
ETB 131.212813
FJD 2.408562
FKP 0.857318
GBP 0.845132
GEL 2.976774
GGP 0.857318
GHS 15.832297
GIP 0.857318
GMD 75.989901
GNF 9010.518536
GTQ 8.047658
GYD 217.718333
HKD 8.106452
HNL 26.542023
HRK 7.681788
HTG 135.959418
HUF 410.896542
IDR 16942.710963
ILS 3.675877
IMP 0.857318
INR 90.014678
IQD 1363.652924
IRR 43824.26542
ISK 146.118712
JEP 0.857318
JMD 163.365869
JOD 0.738454
JPY 162.744156
KES 134.803819
KGS 91.031653
KHR 4196.095255
KMF 491.962147
KPW 936.860903
KRW 1496.551746
KWD 0.320917
KYD 0.867671
KZT 542.362128
LAK 22692.850134
LBP 93196.569507
LKR 310.911084
LRD 202.934565
LSL 19.247218
LTL 3.073674
LVL 0.629664
LYD 5.11628
MAD 10.40592
MDL 19.417176
MGA 4913.314063
MKD 61.532474
MMK 3380.985882
MNT 3537.170063
MOP 8.351798
MRU 41.513457
MUR 48.352199
MVR 16.041213
MWK 1807.618576
MXN 21.341379
MYR 4.624455
MZN 66.527331
NAD 19.247084
NGN 1620.768943
NIO 38.306805
NOK 11.742457
NPR 144.023067
NZD 1.8376
OMR 0.400687
PAB 1.041156
PEN 3.870797
PGK 4.166168
PHP 60.73249
PKR 290.062382
PLN 4.224599
PYG 8235.091411
QAR 3.79012
RON 4.975877
RSD 117.153392
RUB 103.312946
RWF 1449.011352
SAR 3.903939
SBD 8.821823
SCR 14.836374
SDG 625.615326
SEK 11.461935
SGD 1.410709
SHP 0.857318
SLE 23.62895
SLL 21828.335792
SOS 594.901562
SRD 36.51657
STD 21545.696434
SVC 9.110444
SYP 13534.515498
SZL 19.247678
THB 35.29727
TJS 11.39496
TMT 3.653757
TND 3.326376
TOP 2.438027
TRY 37.109758
TTD 7.072641
TWD 34.026804
TZS 2628.415263
UAH 43.728335
UGX 3831.429522
USD 1.040956
UYU 45.562189
UZS 13537.638308
VES 57.972478
VND 26117.596848
VUV 123.584438
WST 2.915539
XAF 653.982049
XAG 0.033826
XAU 0.000378
XCD 2.813236
XDR 0.802178
XOF 654.229378
XPF 119.331742
YER 259.250465
ZAR 19.26425
ZMK 9369.860898
ZMW 29.021522
ZWL 335.187546
  • RBGPF

    0.1600

    62.36

    +0.26%

  • SCS

    -0.2200

    11.58

    -1.9%

  • RYCEF

    0.1500

    7.42

    +2.02%

  • NGG

    -1.5400

    60.05

    -2.56%

  • BTI

    -0.1600

    36.57

    -0.44%

  • GSK

    -0.3500

    33.43

    -1.05%

  • CMSD

    -0.0400

    23.96

    -0.17%

  • CMSC

    -0.0600

    23.49

    -0.26%

  • RIO

    -0.6100

    61.12

    -1%

  • AZN

    0.2400

    68.2

    +0.35%

  • RELX

    -0.2900

    49.26

    -0.59%

  • BCE

    -0.2400

    23.15

    -1.04%

  • BCC

    -1.2000

    127.92

    -0.94%

  • JRI

    -0.0400

    12.53

    -0.32%

  • VOD

    -0.1700

    8.38

    -2.03%

  • BP

    -0.3900

    31.13

    -1.25%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

K.Okada--JT